Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumoursD. Alwyn Dart(Imperial College London), Charlotte L. Bevan(Imperial College London)Endocrine Related CancerJuly 28, 200910.1677/erc-09-0028Cited by 56SaveCiteExport RISWatch citationsRelated PapersAndrogen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer|Oncogene|2019|70The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer|British Journal of Cancer|2023|24